Neurology® Podcast

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. David Anderson and Dr. Michael K. Hehir interview Dr. Anne Lindblad from the EMMES Corporation and Dr. Robert G. Hart from the University of Texas, Health Science Center about their paper on NINDS-sponsored studies. The podcast concludes with Dr. Brandy Fureman interviewing Dr. Walter Koroshetz on the topic of NIH clinical research collaboration for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns and Dr. Richard Lewis interview Dr. Troels Staehelin Jensen from Aarhus University Hospital in Denmark and Dr. Rolf-Detlef Treede from University of Heidelberg in Germany about their paper on neuropathic pain: redefinition. The podcast concludes with Dr. Bernard Chang interviewing Dr. Gary Franklin for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael K. Sowell and Dr. J. D. Bartleson interview Dr. Tamara Pringsheim from Alberta, Canada about her paper on treatment of menstrually related migraine headache. The podcast concludes with a Clinical Pearl session where Dr. Jason Mackey interviews Dr. Elliot Frohman. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Peter Goadsby and Dr. Stephen Silberstein interview Dr. Tony Ho from Merck & Co., Inc. about his paper on oral CGRP antagonist, MK-0974, in acute treatment of migraine. The podcast concludes with Dr. Myla Goldman interviewing Dr. Bruce Levin for Lesson of the Week. The participants had nothing to disclose except for Dr. Silberstein. His Author Disclosure is as follows: Income for speaking, consulting or serving on an advisory board- GlaxoSmithKline, Allergan, AstraZeneca, Endo, Medtronic, Merck, J&J, Pfizer, Pozen, Valeant Pharmaceuticals International (not in excess of $10,000) & Research Support- Allergan (not in excess of $10,000).

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Leslie Jameieh Cloud and Dr. Cynthia Comella interview Dr. Jacques Montplaisir from the Sleep Studies Center at Sacred Heart Hospital in Montreal about his paper on REM sleep behavior disorder. The podcast concludes with Dr. Daniel O. Claassen interviewing Dr. Bradley F. Boeve for Lesson of the Week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns and Dr. David Carr interview Dr. Brian Ott, Professor in the Department of Clinical Neurosciences from Brown Medical School about his paper on drivers with Alzheimer disease. The podcast concludes with Dr. Ted Burns interviewing Dr. Deniz Erten-Lyons, Patient Page Editors, Dr. David Spencer and Dr. Steve Karceski about the Patient Page Section and actual Patient Page published in this issue. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. William S. David and Dr. Steven M. Albert interview Dr. Vincent Meininger, Professor of Neurology at the Saltpetriere in Paris, France about his paper on amyotrophic lateral sclerosis. The podcast concludes with Dr. Richard Leigh interviewing Dr. John Carew for the Lesson of the Week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Benatar and Dr. Beth Lang interview Dr. Francesc Graus from the Hospital Clinic in Barcelona, Spain about his paper on SOX1 antibodies. The podcast concludes with Dr. Harman Bajwa interviewing Dr. Josep Dalmau for Lesson of the Week. Podcast participants had nothing to disclose except for Dr. Dalmau. He has given 1 or 2 talks per year that are sponsored by Athena Diagnostics.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Aman A. Savani and Dr. Thomas Wingo interview Dr. Donald H. Gilden from the University of Colorado about his paper on VZV vasculopathy. The podcast concludes with Dr. Michael Brooke introducing the Humanities section of the journal and then reading three poems by Nina F. Schor published in January 22, 2008 issue. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Justin Sattin and Dr. Kinan K. Hreib interview Dr. Paul Surtees from the University of Cambridge about his paper on depressive disorder and risk of stroke. The podcast concludes with Dr. Robert Hoesch interviewing Dr. Anna Ledegza for Lesson on the Week. Podcast participants had nothing to disclose.